Niosomal delivery of isoniazid - development and characterization

Tropical Journal of Pharmaceutical Research

Volumn 10, Issue 2, 2011, Pages 203-210

  Singh, Gyanendra ^a   Dwivedi, Harinath ^a   Saraf, Shailendra K ^b   Saraf, Shubhini A ^a  

^a BABU BANARASI DAS NATIONAL INSTITUTE OF TECHNOLOGY AND MANAGEMENT   (India)

^b Northern India Engineering College   (India)

Author keywords

Cellular uptake; Drug release; Isoniazid; Macrophage targeting; Niosome; Tuberculosis

Indexed keywords

DICETYL PHOSPHATE; ISONIAZID; NIOSOME;

ANIMAL CELL; ARTICLE; CELL TRANSPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; EVAPORATION; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SPECTROPHOTOMETRY; TUBERCULOSIS; ZETA POTENTIAL;

EID: 79955933353     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v10i2.66564     Document Type: Article

References (18)

1. Chretien J. Tuberculosis Today. Eur. Res. J. 1995; 20: 617-619.
2. Eva CW, Ryan T, Norma A. A Novel Technique For Localized Drug Delivery. Bio Phys J 2009; 96: 681-687.
3. Gursoy A. Liposome Encapsulated antibiotics: physiochemical and antibacterial properties. STP Pharma Science 2000; 10: 285-291.
4. Jain CP, Vyas SP. Preparation and characterization of niosomes containing rifampicin for lung targeting. J. Microencap 1995; 12: 401-407.
5. Dutt M, Khuller GK. Therapeutic efficacy of poly (DL-Lactide-Co-Glycolide) encapsulated antitubercular drugs against Mycobacterium tuberculosis infection induced in Mice. Antimicrob. Agents Chemother 2001; 45: 363-366.
6. Roopa Karki, Mamatha GC, Subramanya G, Udupa N. Preparation, characterization and tissue disposition of niosomes containing isoniazid. Rasayan J. Chem. 2008; 2: 224-227.
7. Uchegbu IF, Vyas SP. Nonionic surfactant-based vesicles (niosomes) in drug delivery. Int. J. Pharm 1998; 172: 33-70.
8. Elbary A, El-laithy HM, Tadros MI. Sucrose stearatebased proniosome-derived Niosomes for the nebulisable delivery of cromolyn sodium. Int. J. Pharm. 2008; 357: 189-198.
9. Hao Y, Zhao F, Li N, Yang Y, Li K. Studies on a high encapsulation of colchicine by a niosome system. Int. J. Pharm. 2002; 244: 73-80.
10. Jain CP, Vyas SP, Dixit VK. Niosomal System for Delivery of Rifampicin to Lymphatics. Int. J. Pharma Sci. 2006; 68: 575-578.
11. Jain CP, Vyas SP. Preparation and characterization of niosomes containing rifampicin for lung targeting. J. Microencap 1995; 12: 401-407.
12. Desai TR, Finlay WH. Nebulization of Niosomal all trans-retinoic acid: an inexpensive alternative to conventional liposomes. Int. J. Pharm. 2002; 241: 311-317.
13. Blazek-Welsh AI, Rhodes DG. A Maltodextrin-based proNiosomes. AAPS PharmSci. 2001; 3: 1-8.
14. Arunothayanun P, Bernard MS, Craig DQM. Effect of processing variables on the physical characteristics of non ionic surfactant vesicles (niosomes) formed from a hexadecyle diglycerol ether. Int J. Pharm. 2000; 201: 7-14.
15. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J. Pharm. 1983; 15: 25-35.
16. Raymond MS, Josbert MM, Marcel AF, Andrienne PJ, Grietje M, Gert S. Liposome encapsulated prednisolone phosphate inhibits growth of established tumor in mice. Neoplasia. 2005; 7: 118-127.
17. Sinko PJ. Martin's Physical Pharmacy and Pharmaceutical Sciences. Edn 5, New York: Lippincott Williams & Wilkins, 2006; pp 503-509.
18. Tamizharasi S, Dubey A, Rathi V, Rathi JC. Development and characterization of niosomal drug delivery of gliclazide. J. Young Pharm. 2009; 3: 205-209.